Nektar Therapeutics (NKTR)
1.34
+0.11
(+8.94%)
USD |
NASDAQ |
Nov 04, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.196 |
December 31, 2019 | 0.1799 |
September 30, 2019 | 0.1668 |
June 30, 2019 | 0.1591 |
March 31, 2019 | 0.1514 |
December 31, 2018 | 0.1438 |
September 30, 2018 | 0.1377 |
June 30, 2018 | 0.1323 |
Date | Value |
---|---|
March 31, 2018 | 4.215 |
December 31, 2017 | 2.792 |
September 30, 2017 | 2.908 |
June 30, 2017 | 72.16 |
March 31, 2017 | 5.450 |
December 31, 2016 | 2.763 |
September 30, 2016 | -3.581 |
June 30, 2016 | -6.180 |
March 31, 2016 | -880.47 |
December 31, 2015 | 37.60 |
September 30, 2015 | 3.201 |
June 30, 2015 | 3.561 |
March 31, 2015 | 1.617 |
December 31, 2014 | 3.440 |
September 30, 2014 | 2.647 |
June 30, 2014 | -3.535 |
March 31, 2014 | -12.74 |
December 31, 2013 | -1.390 |
September 30, 2013 | -2.488 |
June 30, 2013 | -3.083 |
March 31, 2013 | -47.71 |
December 31, 2012 | 2.659 |
September 30, 2012 | 1.311 |
June 30, 2012 | 1.625 |
March 31, 2012 | 1.323 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
0.196
Maximum
Mar 2020
0.0198
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
Eli Lilly and Co | 2.185 |
Esperion Therapeutics Inc | -0.7625 |
NovaBay Pharmaceuticals Inc | -1.128 |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 343.33M |
Total Liabilities (Quarterly) | 263.65M |
Shareholders Equity (Quarterly) | 79.69M |
Current Ratio | 5.149 |